The risk for skin cancer (any type except basal cell carcinoma) was 1.62 times higher among tattooed individuals in the case-control study.

In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo.

The lymph nodes are an important part of the immune system. They help fight off infections and filter harmful substances from ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...